WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008101953) COMPOUNDS OF FORMULA (I) AS SERINE PROTEASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/101953    International Application No.:    PCT/EP2008/052058
Publication Date: 28.08.2008 International Filing Date: 20.02.2008
IPC:
C07D 211/06 (2006.01), C07D 211/22 (2006.01), C07D 207/06 (2006.01), A61K 31/40 (2006.01), A61K 31/4418 (2006.01), A61P 25/28 (2006.01), A61P 37/00 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (For All Designated States Except US).
ZIMMERMANN, Kaspar [CH/CH]; (CH) (For US Only).
BAESCHLIN, Daniel Kaspar [CH/CH]; (CH) (For US Only).
MOUSSAOUI, Saliha [FR/FR]; (FR) (For US Only)
Inventors: ZIMMERMANN, Kaspar; (CH).
BAESCHLIN, Daniel Kaspar; (CH).
MOUSSAOUI, Saliha; (FR)
Agent: VON SPRECHER, Georg; Novartis Pharma AG, Patent Department, CH-4002 Basel (CH)
Priority Data:
07102910.2 22.02.2007 EP
Title (EN) COMPOUNDS OF FORMULA (I) AS SERINE PROTEASE INHIBITORS
(FR) COMPOSÉS DE LA FORMULE (I) UTILISÉS COMME INHIBITEURS DE LA SÉRINE PROTÉASE
Abstract: front page image
(EN)The invention relates to compounds of formula (I) wherein the substituents are as defined in claim 1; to compositions comprising said compounds and to their use as pharmaceutical agents, in particular as inhibitors of serine proteases.
(FR)L'invention se rapporte à des composés de la formule (I) dans laquelle les substituants sont tels que définis dans la revendication 1, à des compositions renfermant lesdits composés et à leur utilisation comme agents pharmaceutiques, en particulier comme inhibiteurs des sérines protéases.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)